Literature DB >> 26143066

Somatic Mutation of ARHI Gene in Hepatocellular Carcinomas.

Chang Jae Kim1, Jung Woo Shin, Seok Won Jung, Bo Ryung Park, Neung Hwa Park.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26143066     DOI： 10.1007/s12253-015-9924-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN： 1219-4956            Impact factor:   3.201


× No keyword cloud information.
  18 in total

1.  Aplasia Ras homologue member I overexpression induces apoptosis through inhibition of survival pathways in human hepatocellular carcinoma cells in culture and in xenograft.

Authors:  Xin-Hong Pei; Zhen Yang; Hong-Xiang Liu; Shi-Shi Qiao
Journal:  Cell Biol Int       Date:  2011-10       Impact factor: 3.612

2.  Hypermethylation of the RUNX3 gene in hepatocellular carcinoma.

Authors:  Won Sang Park; Yong Gu Cho; Chang Jae Kim; Jae Hwi Song; Youn Soo Lee; Su Young Kim; Suk Woo Nam; Sug Hyung Lee; Nam Jin Yoo; Jung Young Lee
Journal:  Exp Mol Med       Date:  2005-08-31       Impact factor: 8.718

3.  Reexpression of ARHI inhibits tumor growth and angiogenesis and impairs the mTOR/VEGF pathway in hepatocellular carcinoma.

Authors:  Xiaohai Zhao; Jinfeng Li; Jianxin Zhuo; Liuxin Cai
Journal:  Biochem Biophys Res Commun       Date:  2010-11-17       Impact factor: 3.575

4.  ARHI/NOEY2 inactivation may be important in breast tumor pathogenesis.

Authors:  Hisashi Hisatomi; Kumi Nagao; Kazuyuki Wakita; Norio Kohno
Journal:  Oncology       Date:  2002       Impact factor: 2.935

Review 5.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

6.  Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.

Authors:  Lin Wang; Ashraful Hoque; Robert Z Luo; Jiuhong Yuan; Zhen Lu; Arata Nishimoto; Jinsong Liu; Aysegul A Sahin; Scott M Lippman; Robert C Bast; Yinhua Yu
Journal:  Clin Cancer Res       Date:  2003-09-01       Impact factor: 12.531

7.  Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.

Authors:  Daniel G Rosen; Lin Wang; Ajay N Jain; Karen H Lu; Robert Z Luo; Yinhua Yu; Jinsong Liu; Robert C Bast
Journal:  Clin Cancer Res       Date:  2004-10-01       Impact factor: 12.531

8.  NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas.

Authors:  Y Yu; F Xu; H Peng; X Fang; S Zhao; Y Li; B Cuevas; W L Kuo; J W Gray; M Siciliano; G B Mills; R C Bast
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

9.  ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis.

Authors:  Jian Huang; Yun Lin; Lihua Li; Deng Qing; Xiao-Mei Teng; Yun-Li Zhang; Xin Hu; Yuanjie Hu; Pengyuan Yang; Ze-guang Han
Journal:  Mol Carcinog       Date:  2009-02       Impact factor: 4.784

10.  NOEY2 mutations in primary breast cancers and breast hyperplasia.

Authors:  Julun Yang; Aiping Hu; Li Wang; Baolin Li; Yue Chen; Wenxing Zhao; Wenmang Xu; Tao Li
Journal:  Breast       Date:  2009-05-30       Impact factor: 4.380
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.